News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Can an oral, alopecia-free treatment improve outcomes for MBC vs paclitaxel? – Paolo Tarantino
Photo from Paolo Tarantino/Twitter
Jul 14, 2023, 07:05

Can an oral, alopecia-free treatment improve outcomes for MBC vs paclitaxel? – Paolo Tarantino

Can an oral, alopecia-free treatment improve outcomes for MBC vs paclitaxel? In METEORA2, just published on JAMA Oncology by Elisabetta Munzone et al, VEX (VNR, endoxan, Xeloda) improved TTF and PFS over paclitaxel, with similar OS and at the cost of G3-4 tox.

https://jamanetwork.com/journals/jamaoncology/fullarticle/2807037

 

Source: Paolo Tarantino / Twitter

OncoDaily Oncology Paolo Tarantino Research
Special Coverage
Insight
Jan 25, 2025, 17:27
Insights from AUC3 by Andrea Necchi
Blog
Jan 25, 2025, 17:18
Bibi Maryam: Ryan Nipp on how focusing on PROs is helpful for patients with pancreatic cancer at ASCO GI
Blog
Jan 25, 2025, 17:17
Registration is still open for the two new courses at the Chelsea campus - The Institute of Cancer Research
Blog
Jan 25, 2025, 17:15
Five ways you can get involved this World Cancer Day - UICC
Blog
Jan 25, 2025, 17:11
Belén Garijo: My three top takeaways from the World Economic Forum 2025
Blog
Jan 25, 2025, 16:58
Wafaa Rashed: The importance of persistence in science
Blog
Jan 25, 2025, 16:55
Carmen Uscatu: What is the music beneath the words?
Blog
Jan 25, 2025, 16:50
Roupen Odabashian: How Helpcare AI is improving patient care by deploying AI agents
Science
Jan 25, 2025, 16:47
Concurrent PIK3CA mutant drives cachexia through inflammatory signaling in EGFR mutant lung cancer
Blog
Jan 25, 2025, 16:25
Melanie Schmid: 21st annual Cincinnati Golf Classic team
Science
Jan 25, 2025, 16:19
Paolo Tarantino: Evolutions in the treatment of HER2+ breast cancer
Blog
Jan 25, 2025, 15:56
No recurrences in MSS colorectal cancer with BOT/BAL neoadjuvant immunotherapy: NEST Trial updates from ASCOGI25